EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohort

D M J Creemers, D M Mens, S Nordkamp, F Piqeur, E Banken, S H J Ketelaers, P W Harmsen, J L Tolenaar, I E G van Hellemond, G M Creemers, H M W Verheul, G A P Nieuwenhuijzen und 9 weitere

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2025.110261 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von D M J Creemers und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Catharina Hospital Eindhoven, the Netherlands; GROW, Research Institute for Oncology and Reproduction, Maastricht University, …. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to assess patient, tumour and treatment characteristics in locally re-recurrent rectal cancer (LrRRC), and relate these to long-term oncological outcomes since limited literature on this topic is available. METHODS: A retrospective study of locally recurrent rectal cancer (LRRC) patients treated with curative intent between 1994 and 2022 in two tertiary centres in the Netherlands. Data on patient, tumour and treatment characteristics were collected. Oncological outcomes of patients treated with curative and palliative intent were displayed. RESULTS: Of 852 curatively treated LRRC patients, 277 (33 %) developed LrRRC. The median survival of this LrRRC group was 23 months (95 % CI 20-26). Treatment with curative intent was offered to 92/277 (33 %) patients, resulting in surgical resection in 81/277 (29 %) patients. Complete oncological clearance (R0) was achieved in 50/81 cases (62 %). Surgical resection resulted in a median survival of 35 months (95 % CI 27-43). Palliative treatment resulted in a median survival of 16 months (95 % CI 11-21). Median progression free survival (PFS) in patients treated with curative intent was 16 months (95 % CI 12-20). Median local re-re-recurrence free survival (LrrRFS) in patients who underwent surgery was 11 months (95 % CI 8-16). CONCLUSION: The median OS in 277 LrRRC patients was 23 months. Aggressive treatment in selected patients resulted in a median OS of 35 months. Furthermore, locoregional control was achieved for 11 months in patients undergoing surgery. These findings underscore the need for meticulous patient selection and tailored treatment strategies to improve survival while minimising unnecessary morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoplasm Recurrence, LocalHumansMaleFemaleRetrospective StudiesMiddle AgedAgedPalliative CareNetherlandsSurvival RateAdultAged, 80 and overProgression-Free SurvivalProctectomy

Stichwörter der Autor:innen

Locally re-recurrent rectal cancerLocally recurrent rectal cancerOncological outcomes

Autor:innen und Institutionen

  • Department of Surgery, Catharina Hospital Eindhoven, the Netherlands; GROW, Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands. Electronic address: davy.creemers@cathari…
  • Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.
  • Department of Surgery, Catharina Hospital Eindhoven, the Netherlands; GROW, Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, the Netherlands.
  • Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands.
  • Department of Surgery, Catharina Hospital Eindhoven, the Netherlands; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.
  • Department of Surgery, Catharina Hospital Eindhoven, the Netherlands.

Zitieren

APA

Creemers, D. M. J., Mens, D. M., Nordkamp, S., Piqeur, F., Banken, E., Ketelaers, S. H. J., Harmsen, P. W., Tolenaar, J. L., van Hellemond, I. E. G., Creemers, G. M., Verheul, H. M. W., Nieuwenhuijzen, G. A. P., Bloemen, J. G., Nederend, J., Verrijssen, A. E., Peulen, H. M. U., Rothbarth, J., Coebergh-van den Braak, R. R. J., Rutten, H. J. T., …, & Burger, J. W. A. (2025). Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohort. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110261

Vancouver

Creemers DMJ, Mens DM, Nordkamp S, Piqeur F, Banken E, Ketelaers SHJ, et al. Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohort. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110261

BibTeX
@article{Creemers2025,
  author = {Creemers, D M J and Mens, D M and Nordkamp, S and Piqeur, F and Banken, E and Ketelaers, S H J and Harmsen, P W and Tolenaar, J L and van Hellemond, I E G and Creemers, G M and Verheul, H M W and Nieuwenhuijzen, G A P and Bloemen, J G and Nederend, J and Verrijssen, A E and Peulen, H M U and Rothbarth, J and Coebergh-van den Braak, R R J and Rutten, H J T and Verhoef, C and Burger, J W A},
  title = {Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohort},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2025.110261}
}
Kostenlos starten →